Open original FDA record ↗Recall record
- FDA identifier
- Z-1710-2026
- Company in FDA record
- Medline Industries, LP
- FDA classification date
- Apr 1, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.
Source facts
- Action
- Firm notified customers on 2/16/26. Consignees were provided with a copy of Olympus's notification, which includes reminders to follow the IFU. According to the firm, the component can continue to be utilized by the customer, along with the remainder of the kit.
- Initiated
- 2026-02-16
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide distribution in the states of CA, FL, IL, IN, KY, MA, MD, MT, NY, OH, PA, TN, TX.
- Recall number
- Z-1710-2026
- Recall status
- Open, Classified
- CDRH record ID
- 218998
- FDA classified
- 2026-04-01
- Recall event number
- 98530